Interestingly, treatment with rapamycin led to increased expression of thyroid-specific genes and NIS protein in thyroid cancer cells with either the BRAF mutation or PTEN deficiency but not in PTC harboring a RET/PTC rearrangement (Table 1) 92. The gene discussed is PTEN; the disease is thyroid cancer.